Zetia claims win magistrate blessing
Glenmark Pharmaceuticals and Merck should have to face pay-for-delay claims over the cholesterol-lowering drug Zetia at trial, a federal magistrate judge has said.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10